Physician

Demetrios Nicholas Panagiotou, M.D.

According to 2025 Medicare claims, Demetrios Panagiotou, M.D. (NPI: 1225284706) practices cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is KEYSTONE CARDIOVASCULAR CENTER LLC (NPI: 1902299621; TIN: 473326858) and primary practice location at 07675-3123. Panagiotou is affiliated with the Englewood Health ACO, LLC (ACO ID: A5653), participating under the MSSP model.

Panagiotou's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,442 traditional Medicare patients, billed 13,641 HCPCS/CPT codes, and received $1,281,279 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 2,594 prescription claims across 341 beneficiaries totaling $338,149 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 12 claims. Open Payments data shows 9 records totaling $206. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $63,934 to $1,281,279. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,008 and ending at $338,149. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	199	761	$63,934
2016	309	1,758	$143,480
2017	664	3,654	$301,912
2018	557	2,908	$268,451
2019	800	4,275	$367,694
2020	901	4,939	$396,186
2021	1,101	6,127	$478,103
2022	1,547	8,466	$657,665
2023	1,890	10,404	$931,814
2024	2,442	13,641	$1,281,279

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	151	$9,008
2016	53	324	$22,817
2017	545	903	$105,692
2018	2,871	4,866	$704,566
2019	5,021	8,113	$1,321,145
2020	1,853	3,386	$580,328
2021	140	1,177	$175,315
2022	167	1,174	$172,787
2023	238	1,537	$232,425
2024	341	2,594	$338,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$76
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$124
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	444	486	$167
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	504	526	$74
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	453	2,974	$72
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	616	2,094	$69
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	909	1,041	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	182	6,525	$126,650
Entresto	Sacubitril/Valsartan	80	2,821	$63,869
Xarelto	Rivaroxaban	37	2,770	$49,696
Nadolol	Nadolol	106	5,247	$4,473
Metoprolol Succinate	Metoprolol Succinate	202	11,724	$3,593

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$206	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Demetrios Nicholas Panagiotou, M.D.?

Tedicare shows public-source Medicare data for Demetrios Nicholas Panagiotou, M.D. (NPI 1225284706), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Demetrios Nicholas Panagiotou, M.D. have ACO affiliation data?

Demetrios Nicholas Panagiotou, M.D. is shown with ACO affiliation data for Englewood Health ACO, LLC (MSSP, ACO ID A5653).

What billing organization is linked to Demetrios Nicholas Panagiotou, M.D.?

Demetrios Nicholas Panagiotou, M.D. is linked to KEYSTONE CARDIOVASCULAR CENTER LLC (billing NPI 1902299621) in the available physician profile data.

Does Demetrios Nicholas Panagiotou, M.D. have Open Payments data?

Demetrios Nicholas Panagiotou, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.